Comunicati.net - Comunicati pubblicati - Lazio Comunicati.net - Comunicati pubblicati - Lazio Wed, 03 Mar 2021 18:26:07 +0100 Zend_Feed_Writer 1.12.20 (http://framework.zend.com) http://comunicati.net/comunicati/istituzioni/comuni/lazio/1 Syringes Market Expected to Reach $32.39 Billion by 2027 Tue, 02 Mar 2021 16:15:28 +0100 http://comunicati.net/comunicati/istituzioni/comuni/lazio/comune_di_roma/municipio_roma_xvi/692844.html http://comunicati.net/comunicati/istituzioni/comuni/lazio/comune_di_roma/municipio_roma_xvi/692844.html Automotive Market Research Reports Automotive Market Research Reports Upsurge in incidence of needle stick injuries, rise in awareness about smart syringes, and high-end technological advancements fuel the growth of the global syringes market. On the other hand, high cost and unaffordability of safety syringes and alternative modes of drug delivery impede the growth to some extent. However, increase in need for safety syringes in emerging economies is expected to create lucrative opportunities in the industry.

The global syringes market size was estimated at $15.34 billion in 2019, and is expected to hit $32.39 billion by 2027, registering a CAGR of 9.6% from 2020 to 2027.

Image for post

The specialized syringes segment to dominate by 2027-

Based on product, the specialized syringes segment accounted for more than two-thirds of the global syringes market share in 2019, and is projected to maintain the lion’s share by the end of 2027. The same segment would also register the fastest CAGR of 10.0% from 2020 to 2027. Surge in use of disposable syringes and rise in demand for injectable drugs drive the growth of the segment.

Rise in incidence of needle stick injuries, increase in awareness about smart syringes, and high-end technological advancements drive the growth of the global syringes market. However, high cost and unaffordability of safety syringes and alternative modes of drug delivery hider the growth to some extent. Nevertheless, rise in need for safety syringes in emerging countries is anticipated to usher a plethora of opportunities for the market players.

Frontrunners in the industry-

  • B. Braun Melsungen AG
  • Becton
  • Dickinson and Company
  • Cardinal Health Inc
  • Gerresheimer AG
  • Hindustan Syringes and Medical Devices Ltd.
  • Medline Industries, Inc
  • Nipro Corporation (Nipro Medical Corporation)
  • Retractable Technologies, Inc
  • Smith’s Group Plc
  • Terumo Corporation (Terumo Medical Corporation)

North America had the major share in 2019-

Based on geography, North America held the major share in 2019, garnering more than two-fifths of the global syringes market. This is due to increase in demand for advanced syringes, availability of well-developed healthcare infrastructure, and presence of major giants in the region. Simultaneously, the market across Asia-Pacific would exhibit the fastest CAGR of 10.8% from 2020 to 2027, owing to improvement in healthcare infrastructure, rise in number of hospitals equipped with advanced medical facilities, development of the R&D sector, rise in healthcare reforms, and technological advancements in the field of healthcare.

Click Here @ https://www.alliedmarketresearch.com/syringes-market-A07514

]]>
Rise in importance of biological and targeted drug therapies, technological developments Fri, 26 Feb 2021 09:48:26 +0100 http://comunicati.net/comunicati/istituzioni/comuni/lazio/anguillara_sabazia/691964.html http://comunicati.net/comunicati/istituzioni/comuni/lazio/anguillara_sabazia/691964.html Automotive Market Research Reports Automotive Market Research Reports The growth of the global cancer biomarkers market is due to surge in adoption of cancer biomarkers primarily for prognostics and diagnostics applications across the global.

Surge in number of patients suffering from various types of cancers such as prostate, breast, and lung cancer, rise in number of clinical trials, and high accuracy & reliability drive the growth of the global cancer biomarkers market. However, high cost associated with drug development and fatal effects of cancer drug therapy restrain the market growth. Furthermore, technological advancements in cancer therapy and focus on advanced treatment protocols are expected to create new growth opportunities for the market players.

Cancer Biomarkers Marketgenerated $10.94 billion in 2019, and is estimated to reach $26.97 billion by 2027, potraying a CAGR of 11.8% from 2020 to 2027. The report offers an extensive analysis of changing market dynamics, key winning strategies, business performance, major segments, and competitive scenarios.

Image for post

Based on biomolecule, the genetic biomarkers segment accounted for the largest share in 2019, holding nearly half of the total share, and is expected to maintain the largest share throughout the forecast period. However, glyco-biomarkers segment is expected to register the highest CAGR of 12.5% from 2020 to 2027.

The global cancer biomarker market has witnessed an unprecedented growth in past few years. Rise in importance of biological and targeted drug therapies, technological developments, and surgein prevalence of various types of cancers contribute toward the cancer biomarker market growth. Moreover, cancer biomarkers are commonly used, as they are more reliable and accurate than other diagnostic techniques. The market is expected to grow at a significant pace during the forecast period.

The market is estimated to gain momentum in developing regions of Asia-Pacific and Latin America. Factors such as rapid urbanization, increase in geriatric population and undiagnosed patients, surge in the adoption of remote patient monitoring devices, rise in disposable income, and surge inawareness about the benefits of cancer biomarkers are expected to boost the market growth in these regions.

Leading market players analyzed in the research include Bio-Rad Laboratories, Abbott Laboratories, Exact Sciences Corporation, Bristol-Myers Squibb Company, Merck KGaA, F.Hoffmann-La Roche Ltd., Qiagen N.V., PerkinElmer, Inc., Thermo Fisher Scientific, Inc., and Siemens AG.

Read More: https://www.alliedmarketresearch.com/cancer-biomarkers-market

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

]]>
BOSTON MUSICA, CAROL MARITATO SBARCA NEGLI STATI UNITI CON IL BRANO “IL MIO TUTTO NEL NIENTE” Mon, 01 Feb 2021 17:38:31 +0100 http://comunicati.net/comunicati/istituzioni/comuni/lazio/comune_di_roma/municipio_roma_xvii/686659.html http://comunicati.net/comunicati/istituzioni/comuni/lazio/comune_di_roma/municipio_roma_xvii/686659.html assotutela assotutela




È tutto pronto per oggi alle ore 18, il debutto di Carol Maritato nella città di Boston con il suo ormai osannato singolo “Il mio tutto nel niente”. Un successo inestimabile quello di questo brano ormai portato alle stelle in tutta Italia e non solo.image.gif

Una opera di grande caratura, che segna un ritorno di personalità e carico di significato della giovanissima interprete Carol Maritato, che ha già all’attivo numerosi singoli e l’obiettivo per questo 2021 è quello di scrivere nuovi brani per contenere quindi l’anima di un moderno cantautorato e la grande duttilità d’interprete grintosa e introspettiva. Il nuovo singolo “Il mio tutto nel niente” è dedicato al nonno della cantante ed è stata scritta sull’onda della emotività di Carol, sul proprio tormento interno, nel ricordo e nella mancanza di un parente che amava profondamente e che era punto di riferimento della sua vita. Dunque, non ci resta che attendere di ascoltare il suo primo atto negli Usa, su Itali-Echo 18, WNTN 1550 AM detta anche Global Echoes. Si può ascoltare in streaming su wntn1550am.com.
]]>
comunicato vaccini Mon, 01 Feb 2021 13:58:22 +0100 http://comunicati.net/comunicati/istituzioni/comuni/lazio/comune_di_roma/municipio_roma_xvii/686610.html http://comunicati.net/comunicati/istituzioni/comuni/lazio/comune_di_roma/municipio_roma_xvii/686610.html assotutela assotutela


Mail priva di virus. www.avast.com
]]>
comunicato prezzi vaccini Sat, 30 Jan 2021 15:55:17 +0100 http://comunicati.net/comunicati/istituzioni/comuni/lazio/comune_di_roma/municipio_roma_xvii/686367.html http://comunicati.net/comunicati/istituzioni/comuni/lazio/comune_di_roma/municipio_roma_xvii/686367.html assotutela assotutela




in allegato...con viva preghiera di pubblicazione
]]>
CS Rebibbia Thu, 14 Jan 2021 16:01:54 +0100 http://comunicati.net/comunicati/istituzioni/comuni/lazio/comune_di_roma/municipio_roma_xvii/683625.html http://comunicati.net/comunicati/istituzioni/comuni/lazio/comune_di_roma/municipio_roma_xvii/683625.html assotutela assotutela
 

Mail priva di virus. www.avast.com
]]>
COMUNICATO SU PIANO PANDEMICO ASSOTUTELA Tue, 12 Jan 2021 11:18:23 +0100 http://comunicati.net/comunicati/istituzioni/comuni/lazio/comune_di_roma/municipio_roma_xvii/683194.html http://comunicati.net/comunicati/istituzioni/comuni/lazio/comune_di_roma/municipio_roma_xvii/683194.html assotutela assotutela


COMUNICATO STAMPA


Più che un intento, la scelta su chi curare sembra un ricatto per convincere ad accettare il Mes

Piano pandemico e ‘triage anagrafico’

Dopo tante polemiche ci siamo: è spuntato il nuovo piano pandemico 2021-2023 del ministero della Salute ed è subito allarme. Tra i vari punti, si paventa anche la possibilità di scegliere chi curare in caso di risorse scarse”. Lo dichiara il presidente di AssoTutela Michel Emi Maritato che precisa: “non cadremo nell’inganno cui sembra tendere tale dichiarazione, ovvero quello della provocazione. Sostenere che tali asserzioni siano inaccettabili è fin troppo ovvio �“ insiste il presidente �“ piuttosto cerchiamo di leggere tra le righe e, per quel poco che sappiamo degli oscuri giochi politici, non vorremmo che tale inqualificabile affermazione nasconda altri intenti”. Maritato va avanti nella sua spiegazione: “guarda caso, si sono subito svegliati i fautori del Mes, sulla cui opportunità non vogliamo discutere in questa sede, e hanno rivendicato il ricorso a tale misura economica da assumere immediatamente. Ecco, il nostro pensiero è che si sia fatto uso del ricatto di ‘triage anagrafico assistenziale’ per convincere i riottosi alla misura di prestito Ue per la nostra sanità. Noi precisiamo che, in un Paese civile, con un servizio sanitario pubblico e universale, non solo non sarebbe etico arrivare alla scelta selettiva su chi assistere e chi no ma non è nemmeno ammissibile che qualcuno utilizzi strumenti programmatori quale il piano pandemico, per volgerlo a biechi interessi di durata dell’esecutivo e mantenimento delle poltrone, piuttosto che alla tutela della salute dei cittadini. Sono mezzi da basso impero”, chiosa il presidente.



Roma, 12 gennaio 2021


 
Le informazioni contenute nella presente comunicazione e i relativi allegati possono essere riservate e sono, comunque, destinate esclusivamente alle persone o alla Società sopraindicati.
La diffusione, distribuzione e/o copiatura del documento trasmesso da parte di qualsiasi soggetto diverso dal destinatario è proibita, sia ai sensi dell'art. 616 c.p. , che ai sensi del D.Lgs. n. 196/2003.
Se avete ricevuto questo messaggio per errore, vi preghiamo di distruggerlo e di informarci immediatamente per telefono allo 0645421734 fax 0645421884 o inviando un messaggio all'indirizzo STUDIO.MARITATO@GMAIL.COM .
--------------------------------------------------------------------------------------------------------------------------------------------------

Confidentially notice. This e-mail transmission may contain legally privileged and/or confidential information. Please do not read it if you are not the intended recipient(S). Any use, distribution, reproduction or disclosure by any other person is strictly prohibited. If you have received this e-mail in error, please notify the sender and destroy the original transmission and its attachments without reading or saving it in any manner.

--------------------------------------------------------------------------------------------------------------------------------------------------

Ce message e-mail contient des informations confidentielles sont exclusivement destinés au destinataire indiqué ci-dessus. Et «L'utilisation, la diffusion, la distribution ou la reproduction par toute autre personne. Si vous avez reçu ce courriel par erreur, s'il vous plaît aviser immédiatement l'expéditeur et de détruire ce qui a été reçue (y compris les pièces jointes) sans faire de copie. L'utilisation non autorisée du contenu de ce message est strictement interdite par la confidentialité de la correspondance entre les parties, sauf l'infraction la plus grave, et s'il vous plaît aviser les conséquences.

--------------------------------------------------------------------------------------------------------------------------------------------------

هذه رسالة بريد إلكتروني يحتوي على معلومات سرية تهدف حصرا للالمرسل هو مبين أعلاه. و 'استخدام ونشر والتوزيع أو الاستنساخ من قبل أي شخص آخر. إذا كنت قد تلقيت هذه الرسالة عن طريق الخطأ ، الرجاء إبلاغ المرسل فورا وتدمير ما تم استلام (بما في ذلك المرفقات ملف) دون تقديم نسخة. يمنع منعا باتا الاستخدام غير المرخص لمحتويات هذه الرسالة على سرية المراسلات بين الأطراف الاخرى ، باستثناء جريمة أخطر ، والرجاء إبلاغ عن العواقب.

Please consider the environment before printing this email.


 


 
cid:image002.png@01D1BA8A.422577E0                                        
]]>
Industry closures and people are asked to stay in their homes which has cause taken a huge toll in terms of money and economic growth Thu, 07 Jan 2021 06:47:10 +0100 http://comunicati.net/comunicati/istituzioni/comuni/lazio/comune_di_roma/municipio_roma_xv/682257.html http://comunicati.net/comunicati/istituzioni/comuni/lazio/comune_di_roma/municipio_roma_xv/682257.html Automotive Market Research Reports Automotive Market Research Reports Direct-to-consumer genetic testing is beneficial for people residing in remote areas as it provides people access to their genetic information at ease without visiting the hospital or getting involved with a healthcare provider or health insurance company in the process. Some consumers of DTC genetic testing view it as an opportunity to gather essential medical information about themselves. The DTC genetic testing is of three types mainly; Ancestry tests, which can be used to investigate an individual’s deep ancestry; Paternity tests, which have been used to establish definitive parental rights and health information and Disease Risk test, which is used in disease risk assessments of diseases like cancer, obesity, Alzheimer’s disease, and heart attacks.

The rising incidences of genetic diseases such as cancer across the world along with escalating patient count in developed economic regions like North America and Europe demanding for personalization of genetic testing service will surge the demand for DTC genetic testing. Various genetic predisposition to several genetic diseases can be detected in earlier stages with the use of DTC genetic tests. Growing acceptance of DTC genetic testing due to its capabilities of early disease diagnosis and recognition of genetic mutation preceding its manifestation will further propel the DTC genetic testing market. In addition, the fears of genetic discrimination push the DTC testing, as a significant alternative to undergoing testing, because it allows individuals to keep their test results out of their medical records. In the U.S., implementation of the Genetic Information Nondiscrimination Act (GINA) in May 2008 is expected to reduce consumer fears in this area.

Companies covered:

  • Easy DNA
  • Ancestry
  • Color Genomics
  • Full Genome Corporation
  • Helix OpCo LLC
  • Identigene
  • Karmagenes
  • FamilytreeDNA
  • Mapmygenome
  • Pathway genomics
  • Genesis Healthcare

COVID – 19 scenario analysis:  

  • The COVID-19 pandemic has emerged as a humanitarian as well as economic crisis, creating strain on the society and affecting millions of people and businesses
  • Industry closures and people are asked to stay in their homes which has cause taken a huge toll in terms of money and economic growth
  • Over 4 million people affected globally, with 300 thousand losing their lives due to SARS-CoV-2
  • Healthcare organizations are already working in battle mode, preparing new plans to respond growing COVID-19 patients, right from sourcing rapid diagnosing kits to sufficient PPE kits for workers

Recent technological advancements owing to R&D activities have enabled researchers and healthcare professionals to decode the information in human genetic material and derive valuable insights to aid in the treatment of various diseases. This has led to development of wide verity of direct-to-consumer genetic tests resulting into opportunities for expansion of the market.

]]>
BEFANA AI RICOVERATI PER COVID ALL'OSPEDALE SAN GIOVANNI DI ROMA Tue, 05 Jan 2021 11:10:23 +0100 http://comunicati.net/comunicati/istituzioni/comuni/lazio/comune_di_roma/municipio_roma_xvii/681857.html http://comunicati.net/comunicati/istituzioni/comuni/lazio/comune_di_roma/municipio_roma_xvii/681857.html assotutela assotutela
ROMA, LE CALZETTE DI ASSOTUTELA ALL'OSPEDALE SAN GIOVANNI TRA SORRISI E SOLIDARIETÀ 

“Non si fermano le iniziative benefiche di Assotutela che anche quest’anno, come ormai consuetudine, ha voluto portare sorrisi e solidarietà nelle strutture sanitarie del territorio capitolino. Dopo l'Albero di Natale al San Camillo, l'associazione del presidente Michel Emi Maritato ha deciso di festeggiare la Befana all'ospedale San Giovanni, donando 200 calzette che verranno distribuite ai pazienti, ai medici, agli infermieri e alle oo ss dei tre reparti del celebre nosocomio capitolino. 

“A causa dell’emergenza covid - spiegano le vicepresidenti di Assotutela, le sorelle Emanuela e Carol Maritato - non abbiamo potuto consegnarle personalmente ma le abbiamo portate a tre grandi eccellenze italiane in ambito sanitario e sociale che Assotutela ha designato per l’anno 2020: Michele Milano, Mario Martone e Sonia Silvestrini che stanno consegnando proprio in queste ore le calzette ai pazienti e al personale del Pronto soccorso e dei reparti di III Medicina e Gastroenterologia”.

“Ringrazio tutti coloro che si sono spesi per questa iniziativa - ha sottolineato poi il presidente Maritato -. Le calzette vengono consegnate per donare un sorriso ai pazienti e come ringraziamento a medici, infermieri e oss per il gran lavoro profuso  soprattutto in questo periodo di grande emergenza sanitaria”. Milano, Martone e Silvestrini, infine, hanno voluto ringraziare Assotutela “per il continuo sostegno e il costante aiuto nei confronti del personale sanitario” e spiegano di “lavorare giornalmente con un unico e fondamentale obiettivo: la serenità e la salute del paziente”.

 
.

 


 
cid:image002.png@01D1BA8A.422577E0                                        
]]>
COMUNICATO STAMPA URGENTE RegioneLazio: grandi manovre per la nomina Dg Mon, 04 Jan 2021 20:46:56 +0100 http://comunicati.net/comunicati/istituzioni/comuni/lazio/comune_di_roma/municipio_roma_xvii/681778.html http://comunicati.net/comunicati/istituzioni/comuni/lazio/comune_di_roma/municipio_roma_xvii/681778.html assotutela assotutela

COMUNICATO STAMPA


Si scaldano i motori per scegliere i nuovi manager di Asl e ospedali nella lista degli idonei

Regione Lazio: grandi manovre per la nomina Dg


Inizio anno importante per la Regione Lazio. Pressata dalle esigenze della vaccinazione di massa, preoccupata per le misure di contenimento da attuare, stressata dal problema della ripresa delle scuole con i contagi che non si abbassano, si trova anche a dover decidere sulla scelta dei direttori generali delle più importanti Asl e ospedali del territorio”. Lo dichiara il presidente di AssoTutela Michel Emi Maritato, che chiarisce: “a fine ottobre, è stato pubblicato sul bollettino ufficiale dell’ente l’elenco dei prescelti a ricoprire il ruolo di vertice, con molti nomi noti e qualche sorpresa. Perfino candidati inidonei per legge �“ attacca il presidente �“ o soggetti coinvolti in altri contesti in episodi giudiziari, vedi scandalo sanità umbra, e ammessi quindi con riserva. Non mancano i cosiddetti ‘inconferibili’ come quel Pietro Grasso attualmente direttore sanitario del Columbus afferente alla Fondazione Irccs Gemelli, la struttura privata accreditata dalla Regione Lazio da tempo in crisi ma salvata e trasformata in un batter d’occhio in ospedale Covid all’esplodere dell’epidemia. Peccato �“ continua Maritato �“ che l’articolo 5 comma 1 del decreto legislativo dell’8 aprile 2013 preveda che gli incarichi di vertice in Asl e ospedali non possono essere conferiti a coloro che, nei due anni precedenti, abbiano svolto attività e ricoperto cariche in enti di diritto privato regolati o finanziati dal servizio sanitario regionale. Tutto questo dimostra �“ insiste il presidente �“ che, al di là delle sbandierate procedure di nomina con nuovi criteri di trasparenza, si insiste nelle scelte operate nelle stanze dei bottoni, senza coinvolgere gli addetti del settore, in un momento particolarmente delicato e senza informare l’opinione pubblica su procedure da cui dipende la salute della collettività”.





 
Le informazioni contenute nella presente comunicazione e i relativi allegati possono essere riservate e sono, comunque, destinate esclusivamente alle persone o alla Società sopraindicati.
La diffusione, distribuzione e/o copiatura del documento trasmesso da parte di qualsiasi soggetto diverso dal destinatario è proibita, sia ai sensi dell'art. 616 c.p. , che ai sensi del D.Lgs. n. 196/2003.
Se avete ricevuto questo messaggio per errore, vi preghiamo di distruggerlo e di informarci immediatamente per telefono allo 0645421734 fax 0645421884 o inviando un messaggio all'indirizzo STUDIO.MARITATO@GMAIL.COM .
--------------------------------------------------------------------------------------------------------------------------------------------------

Confidentially notice. This e-mail transmission may contain legally privileged and/or confidential information. Please do not read it if you are not the intended recipient(S). Any use, distribution, reproduction or disclosure by any other person is strictly prohibited. If you have received this e-mail in error, please notify the sender and destroy the original transmission and its attachments without reading or saving it in any manner.

--------------------------------------------------------------------------------------------------------------------------------------------------

Ce message e-mail contient des informations confidentielles sont exclusivement destinés au destinataire indiqué ci-dessus. Et «L'utilisation, la diffusion, la distribution ou la reproduction par toute autre personne. Si vous avez reçu ce courriel par erreur, s'il vous plaît aviser immédiatement l'expéditeur et de détruire ce qui a été reçue (y compris les pièces jointes) sans faire de copie. L'utilisation non autorisée du contenu de ce message est strictement interdite par la confidentialité de la correspondance entre les parties, sauf l'infraction la plus grave, et s'il vous plaît aviser les conséquences.

--------------------------------------------------------------------------------------------------------------------------------------------------

هذه رسالة بريد إلكتروني يحتوي على معلومات سرية تهدف حصرا للالمرسل هو مبين أعلاه. و 'استخدام ونشر والتوزيع أو الاستنساخ من قبل أي شخص آخر. إذا كنت قد تلقيت هذه الرسالة عن طريق الخطأ ، الرجاء إبلاغ المرسل فورا وتدمير ما تم استلام (بما في ذلك المرفقات ملف) دون تقديم نسخة. يمنع منعا باتا الاستخدام غير المرخص لمحتويات هذه الرسالة على سرية المراسلات بين الأطراف الاخرى ، باستثناء جريمة أخطر ، والرجاء إبلاغ عن العواقب.

Please consider the environment before printing this email.


 


 
cid:image002.png@01D1BA8A.422577E0                                        
]]>
comunicato urgente vaccini Wed, 30 Dec 2020 16:02:11 +0100 http://comunicati.net/comunicati/istituzioni/comuni/lazio/comune_di_roma/municipio_roma_xvii/681181.html http://comunicati.net/comunicati/istituzioni/comuni/lazio/comune_di_roma/municipio_roma_xvii/681181.html assotutela assotutela


COMUNICATO STAMPA



Il modulo di consenso informato solleva molti interrogativi, non spiegando effetti a lungo termine

Vaccini, chi risponde in caso di danni futuri?


In questi giorni ricchi di informazioni orientate in un’unica direzione, ovvero la persuasione alla vaccinazione, noi che sosteniamo tale opportunità ma siamo amanti della verità, ci siamo ben documentati sui siti istituzionali e interpellando esperti”. Lo dichiara il presidente di AssoTutela Michel Emi Maritato che spiega: “ci interessano soprattutto aspetti legati all’efficacia e alla sicurezza del vaccino anti Covid 19 prodotto con tecnologia a ‘mRna’ in quanto non è stato possibile avere notizie precise sulla immunizzazione a sei mesi dall’assunzione e non abbiamo trovato informazioni ufficiali sulla sicurezza nel medio e lungo termine”. Il presidente spiega il motivo delle perplessità suscitate: “alcuni operatori sanitari, ben felici di ricevere la loro prima dose dell’antidoto, hanno però espresso dei dubbi relativi al modulo di consenso informato e alle clausole lì riportate, che gli operatori sanitari hanno dovuto sottoscrivere. Nel documento si evidenzia che “non è possibile fare previsioni sui danni a lunga distanza �“ sottolinea Maritato �“ che ci auguriamo non si verifichino. Stupisce pertanto che la Regione Lazio non abbia sottoscritto una assunzione di responsabilità con la costituzione di un eventuale fondo per ristoro in caso di ipotetici effetti collaterali avversi. Secondo noi l’assessore alla Sanità Alessio D’Amato e il presidente Nicola Zingaretti dovrebbero illustrare le reazioni avverse riportate negli studi clinici ed elencate nei registi dell’Agenzia europea del farmaco. Inoltre �“ chiosa Maritato �“ ci saremmo aspettati informazioni precise sulle alternative terapeutiche”.




Roma, 30 dicembre 2020

 


                                    
]]>
Biosimilars Market is supported by a CAGR of 49.1% during the forecast period 2015 to 2027. Wed, 30 Dec 2020 10:10:24 +0100 http://comunicati.net/comunicati/istituzioni/comuni/lazio/comune_di_roma/municipio_roma_xv/681082.html http://comunicati.net/comunicati/istituzioni/comuni/lazio/comune_di_roma/municipio_roma_xv/681082.html Automotive Market Research Reports Automotive Market Research Reports Global biosimilars market was valued at $2,552.0 million in 2014 and is expected to reach $26,551.3 million by 2020, supported by a CAGR of 49.1% during the forecast period 2015 to 2027.

The commercialization of filgrastim biosimilars in the United States have brought the revolutionary changes in development of biosimilars. Pharmaceutical companies interested in investing into biosimilars market are now focusing on the agreement and acquisitions, in order to expand their presence in biosimilars market. Recently, the Pfizer has acquired Hospira, a global leader in biosimilars. This acquisition has strengthen the biosimilar portfolio of Pfizer. Also, it increases the global reach of Hospira through commercial capabilities, scientific expertise of Pfizer. The key companies profiled in the report are Novartis (Sandoz), Synthon Pharmaceuticals, Inc., Teva Pharmaceutical Industries Ltd., LG Life Sciences, Celltrion, Biocon, Hospira, Merck Serono (Merck Group), Biogen idec, Inc., and Genentech (Roche Group). 

Recent approval of Zarxio (filgrastim-sndz) as first biosimilar by U.S. FDA has opened new opportunities for biosimilar manufactures. Patents for number of blockbuster bio-pharmaceuticals have either expired or are on the verge of expiration, which is majorly driving the growth of biosimilars industry. Changes in regulatory guidelines and convenient biosimilar drug approval processes have a major impact on the commercial growth of global biosimilars market. However, the high investment associated with research and development, longer development processes and requirements of economies of scale for profitability largely limit the growth of biosimilars market. The integration of developmental plan with regulatory guidelines and the adoption of optimal commercial strategies would play crucial role in commercial growth of biosimilars market.

Key findings of Global Biosimilars Market:

  • The biosimilar applications in blood disorders and oncology collectively evaluated at 61% in 2014
  • Interferon is fastest growing biosimilar, expected to grow at a CAGR of 51.1% during the forecast period
  • U.S. would find space in biosimilar market with single-digit revenue share of overall biosimilar market by 2020

Glycosylated proteins namely, erythropoietin and monoclonal antibodies are the leading biosimilar segments commercially available across the globe, together accounting for about one-third of the market revenue in 2014. This significant hold in the market is chiefly due to its large application in the treatment of chronic conditions such as blood related disorders, cancer, among others.

Key findings of the study: 

The biosimilar applications in blood disorders and oncology collectively evaluated at 61% in 2014Interferon is fastest growing biosimilar, expected to grow at a CAGR of 51.1% during the forecast periodU.S. would find space in biosimilar market with single-digit revenue share of overall biosimilar market by 2020.

]]>
Powered Surgical Instrument Market is registering a CAGR of 4.2% through 2025 Mon, 28 Dec 2020 08:35:15 +0100 http://comunicati.net/comunicati/istituzioni/comuni/lazio/comune_di_roma/municipio_roma_xv/680597.html http://comunicati.net/comunicati/istituzioni/comuni/lazio/comune_di_roma/municipio_roma_xv/680597.html Automotive Market Research Reports Automotive Market Research Reports The global powered surgical instrument market was pegged at $1.94 billion in 2017 and is expected to garner $2.73 billion by 2025, registering a CAGR of 4.2% through 2025. High prevalence of chronic disease rise in global geriatric population and increase in healthcare expenditure are expected to propel the growth of the global powered surgical instrument market. 

Based on product, the market is divided into power source & controls, accessories and handpieces.  Handpieces section is further segmented into six sub divisions namely reamer systems, saw systems, drill systems, shavers, stapler, and others. Power source & controls segment has three sub sections including electric consoles, pneumatic regulators and batteries. Surgical accessories and electrical accessories round off the accessories segment. The accessories segment is expected to garner the highest CAGR throughout the forecast period. This is due to low cost and bulk purchase.

Handpieces segment to dominate the market throughout the study period 

The handpieces segment held the largest share in 2017, contributing about two-thirds of total market revenue, owing to the growing demand for minimally invasive surgery and rapid adoption of technologically advanced surgical instruments. However, the accessories segment is expected to register the fastest CAGR of 5.1% during the study period, owing to frequent change of surgical and electrical accessories due to occurrence of wear and tear of accessories over time. The power source & controls segment is expected to witness steady growth during the forecast period.

The report includes an in-depth analysis of research methodology, market scope, market dynamics, market share analysis, product pipeline analysis, key market segments, key growth factors & opportunities, market size & forecast, business performance, key strategic moves and operating business segments. Rise in geriatric population, increase in the number of chronic diseases, growing rate of surgical procedures across the globe and especially, mounting demand for minimally invasive surgeries have rocketed the growth of global powered surgical instrument market. On the other hand, high-price rivalry and unfavorable taxation policy have happened to restrain the growth to certain extent. Nevertheless, various growth opportunities from emerging economies have spurred the growth yet again.

Plastic surgery segment to manifest rapid growthby 2025 

The plastic surgery segment is estimated to register the fastest CAGR of 6.2% from 2017 to 2023, owing to the growing demand for cosmetic surgeries, increasing incidence of cancer, and growing age-related surgeries across the globe. However, the orthopedic surgery segment accounted the largest share, contributing about 21% share of the market, owing to increased demand for minimally invasive surgery in orthopedics and rise in geriatric population. The other segments analyzed in the report include neurosurgery, ENT surgery, cardiovascular surgery, cardiothoracic surgery, and others.

North America governs the market in 2017 

North America held the largest share in the global powered surgical instrument market, garnering about half of the total revenue in 2017, owing to highly sophisticated healthcare infrastructure and high adoption rate of technologically advanced surgical tools in the region. However, Asia-Pacific region is expected to portray the fastest CAGR of 5.4% during the forecast period, owing to high prevalence of chronic diseases and rise in demand of minimally invasive surgery. The other regions analyzed in the report include Europe and Latin America, Middle East and Africa (LAMEA).

Torchbearers of the market 

The key players analyzed in the report include De Soutter Medical Ltd., Peter Brasseler Holdings, LLC, Intrauma S.p.A., GEISTER Medizintechnik GmbH, and Ruijin Medical Instrument & Device Co., Ltd.

Web: https://www.alliedmarketresearch.com

SOURCE Allied Market Research

]]>
Pharmaceutical Grade Sodium Chloride Market Players to Reset their Production Strategies Post 2020 in an Effort to Compensate for Heavy Loss Incurred Due to COVID-19 Outbreak Wed, 23 Dec 2020 13:22:45 +0100 http://comunicati.net/comunicati/istituzioni/comuni/lazio/comune_di_roma/municipio_roma_xv/680278.html http://comunicati.net/comunicati/istituzioni/comuni/lazio/comune_di_roma/municipio_roma_xv/680278.html Ankush Nikam Ankush Nikam Pharmaceutical Grade Sodium Chloride Market Analysis 2019 - 2029

A recent market study published by FMI on the pharmaceutical grade sodium chloride market includes global industry analysis for 2014-2018 & opportunity assessment for 2019-2029, and delivers a comprehensive assessment of the market dynamics. After thorough research on the historical as well as current growth parameters of the pharmaceutical grade sodium chloride market, the growth prospects of the market are obtained with maximum precision.

For more insights into the Market, request a sample of this report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-6464

Pharmaceutical Grade Sodium Chloride Market: Segmentation

Type

Application

Region

  • API-NaCl
  • HD-NaCl
  • Injections
  • Hemodialysis
  • Oral Rehydrations Salts
  • Osmotic Agents
  • Others
  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

Report Chapters

Chapter 01 – Executive Summary

Executive summary of the pharmaceutical grade sodium chloride market with insights on supply-side as well as demand-side trends of the market.

Chapter 02 – Market Overview

The market overview includes market definition and taxonomy to give the reader a market description of pharmaceutical grade sodium chloride.

Chapter 03 – Key Market Trends

The section overviews the key trends impacting the market at the global and regional levels.

Chapter 04 – Key Success Factors

Factors and strategies adopted by key market participants, which have a significant impact on the pharmaceutical grade sodium chloride market.

Chapter 05 - Global Pharmaceutical Grade Sodium Chloride Market Volume (Consumption) Projections

Market volume projection in terms of consumption over the forecast period of 2019-2029 are given in this chapter.

Chapter 06 - Global Pharmaceutical Grade Sodium Chloride Market - Pricing Analysis

This section helps readers analyze pricing trends owing to the necessary assumptions.

Chapter 07 – Global Pharmaceutical Grade Sodium Chloride Market Demand (in Value or Size in US$ Mn) Analysis 2014-2018 and Forecast 2019-2029

This section helps readers understand the global market value analysis and forecast for the pharmaceutical grade sodium chloride market.

Chapter 08 – Market Background

Key macroeconomic factors, value chain, market participants, and consumption & production are highlighted in this chapter.

Chapter 09 – Porter’s Analysis

In the section, Porter’s Analysis is used for analyzing competition.

Chapter 10 – Global Pharmaceutical Grade Sodium Chloride Market Analysis by Type

Based on form, the pharmaceutical grade sodium chloride market is segmented into API-NaCl and HD-NaCl.

Chapter 11 - Global Pharmaceutical Grade Sodium ChlorideMarket Analysis by Application

The pharmaceutical grade sodium chloride market is segmented on the basis of applications such as injections, hemodialysis, oral rehydration salts, osmotic agents, and others.

Chapter 12 – Global Pharmaceutical Grade Sodium Chloride Market Analysis by Region

This chapter explains how the pharmaceutical grade sodium chloride market will grow across various geographic regions.

Chapter 13 – North America Pharmaceutical Grade Sodium Chloride Market Analysis

Detailed analysis on the basis of segments at the country level for the U.S. and Canada.

Chapter 14 – Latin America Pharmaceutical Grade Sodium Chloride Market Analysis

Detailed analysis on the basis of segments at the country level for Brazil, Mexico, and Rest of Latin America.

Chapter 15 – Europe Pharmaceutical Grade Sodium Chloride Market Analysis

Important growth prospects of the pharmaceutical grade sodium chloride market based on its end users in several countries such as Germany, Italy, France, Spain, the U.K., Russia, Benelux, and the rest of Europe are included in this chapter.

Chapter 16 – South Asia Pharmaceutical Grade Sodium Chloride Market Analysis

This chapter highlights the growth of the pharmaceutical grade sodium chloride market in South Asia by focusing on India, ASEAN, and the Rest of South Asia.

Chapter 17 – East Asia Pharmaceutical Grade Sodium Chloride Market Analysis

Market analysis for Japan, China, and South Korea is given as these are the prominent countries in the East Asia region.

Chapter 18 – Oceania Pharmaceutical Grade Sodium Chloride Market Analysis

Analysis of pharmaceutical grade sodium chloride market in countries such as Australia and New Zealand during the forecast period.

Chapter 19 – MEA Pharmaceutical Grade Sodium Chloride Market Analysis

Growth of the pharmaceutical grade sodium chloride market in MEA by focusing on South Africa, Turkey, GCC Countries, and the Rest of MEA is given here.

Chapter 20 – Emerging Countries Pharmaceutical Grade Sodium Chloride Market Analysis

This chapter highlights the emerging countries in the pharmaceutical grade sodium chloride market, which show a substantial growth rate in the market.

Chapter 21 – Market Structure Analysis

This section covers market concertation, analysis of the top players, and tier analysis of companies.

Table Of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

2. Market Overview

    2.1. Taxonomy

    2.2. Market Definition

    2.3. Parent Market Overview

    2.4. Production Process Overview

3. Key Market Trends

    3.1. Key Trends Impacting the Market

4. Key Success Factors

5. Global Pharmaceutical Grade Sodium Chloride Market Demand Analysis 2014-2018 and Forecast, 2019-2029

    5.1. Historical Market Volume (Mn Units) Analysis, 2014-2018

    5.2. Current and Future Market Volume (Mn Units) Projections, 2019-2029

    5.3. Y-o-Y Growth Trend Analysis

6. Global Pharmaceutical Grade Sodium Chloride Market - Pricing Analysis

    6.1. Regional Pricing Analysis By Application

    6.2. Import Vs Sales Price Analysis

    6.3. Pricing Break-up

        6.3.1. Manufacturer Level Pricing

        6.3.2. Distributor Level Pricing

    6.4. Global Average Pricing Analysis Benchmark

7. Global Pharmaceutical Grade Sodium Chloride Market Demand (in Value or Size in US$ Mn) Analysis 2014-2018 and Forecast, 2019-2029

    7.1. Historical Market Value (US$ Mn) Analysis, 2014-2018

    7.2. Current and Future Market Value (US$ Mn) Projections, 2019-2029

        7.2.1. Y-o-Y Growth Trend Analysis

        7.2.2. Absolute $ Opportunity Analysis

Request To Browse Full Table of Content, Figure And Tables @ https://www.futuremarketinsights.com/toc/rep-gb-6464

Chapter 22 – Competition Landscape

Some of the market players featured in the report are K+S AG, Akzonobel, Swiss Saltworks, and Dominion Salt Ltd., among others.

Chapter 23 – Assumptions and Acronyms

This chapter includes a list of acronyms and assumptions that provides a base to the information and statistics included in the pharmaceutical grade sodium chloride market report.

Chapter 24 – Research Methodology

This chapter help readers understand the research methodology followed to obtain various conclusions as well as important qualitative and quantitative information about the pharmaceutical grade sodium chloride market.

]]>
China is projected to register the highest growth rate in Asia-Pacific. Thu, 10 Dec 2020 20:57:33 +0100 http://comunicati.net/comunicati/istituzioni/comuni/lazio/comune_di_roma/municipio_roma_xv/677541.html http://comunicati.net/comunicati/istituzioni/comuni/lazio/comune_di_roma/municipio_roma_xv/677541.html Automotive Market Research Reports Automotive Market Research Reports The global cord blood banking services market accounted for $1,126 million in 2016, and is estimated to reach at $2,772 million by 2023, registering a CAGR of 13.8% from 2017 to 2023. North America was the highest revenue contributor in the global market in 2016.

The global cord blood banking services market is driven by factors including various marketing strategies adopted by key players, rise in R&D activities for cord blood applications, and surge in funding for establishing public cord blood storage banks.

The global cord blood banking services market is driven by factors including various marketing strategies adopted by key players, rise in R&D activities for cord blood applications, and surge in funding for establishing public cord blood storage banks. However, expensive nature of the processing, adversities related to find a match in the donor list, and legal & ethical issues regarding gathering of cord blood hinder the market growth. On the other hand, advancements related stem cell therapeutics and untapped potential in the developing regions would offer opportunities for the market growth.

In 2016, North America held the largest share in terms of the total revenue, owing to surge in awareness among expectant parents, rise in disposable income, and high rate of adoption of cord blood storage services. On the other hand, Asia-Pacific is estimated to register the highest growth during the forecast period, attributable to rise in focus of key players for extending their services and surge in disposable income.

The private cord blood banks segment occupied a dominant part of the market in 2016, and is expected to grow at the highest rate. This is attributable to the better service provided by the private banks to their customers, guarantee of storing the cord blood for a specified period, and immediate retrieval of the cord blood when required for treatment of any genetic disease.

Key findings of the report:

  • The private cord blood bank segment is expected to register the highest growth rate during the forecast period.
  • Germany contributed the highest revenue in the European market in 2016, and is projected to maintain its dominant position during the forecast period.
  • In 2016, North America held the largest share in the global cord blood banking services market, and is expected to maintain this trend in coming years.
  • China is projected to register the highest growth rate in Asia-Pacific.

The key companies analyzed in the report are China Cord Blood Corporation, CBR Systems, Inc., Cord Blood America, Inc., Cryo-Cell International, Inc., Cordlife Group Limited, Lifeforce Cryobanks, Cryo-Save AG, ViaCord, Inc., National Cord Blood Program, CordVida, Virgin Health Bank, CryoHoldco, and Vita34.

Press Release: https://www.alliedmarketresearch.com/press-release/cord-blood-banking-services-market.html

]]>
U.S. accounted for more than half of the overall market in 2017, whereas South Korea is expected to register the highest CAGR of 9.7%. Tue, 08 Dec 2020 20:03:25 +0100 http://comunicati.net/comunicati/istituzioni/comuni/lazio/anguillara_sabazia/677035.html http://comunicati.net/comunicati/istituzioni/comuni/lazio/anguillara_sabazia/677035.html Automotive Market Research Reports Automotive Market Research Reports Global bone grafts and substitutes market was pegged at $2.69 billion in 2017 and is expected to reach $3.91 billion by 2025, registering a CAGR of 4.8% from 2018 to 2025.

Rapid development of novel bone grafts materials such as biocompatible synthetic bone grafts and rise in prevalence of bone and joint disorders are the major factors driving the growth of the global bone grafts and substitutes market. Moreover, surge in the number of patients suffering from rheumatoid arthritis, osteoarthritis, and other joint disorders have supplemented the market growth. However, high cost of surgeries and several ethical issues associated with bone grafting procedures have hampered the market development. On the contrary, increasing inclination of key market players toward R&D activities and surge in demand for orthopedic procedures among geriatric population would provide lucrative opportunities for the market leaders in the coming years.

The use of bone grafts and substitutes reduces the need to harvest autograft bones from patients, which in turn reduces postoperative pain and healing time. Increased use of bone graft substitutes facilitates minimally invasive surgeries and short surgical procedures. Although these procedures were initially used for spinal fusion and rectification of deformities, the adoption of these procedures has increased for various applications, including extremity reconstruction and treatment of fractures. 

ALLIED MARKET RESEARCH

Key Findings of the Bone Grafts and Substitutes Market:

  • Bone graft substitutes segment dominated the overall market with a share of more than half of the overall market in 2017, and is expected to continue to lead the during the forecast period.
  • Asia-Pacific is expected to witness highest market growth rate, with a CAGR of 7.3% from 2018-2025
  • U.S. accounted for more than half of the overall market in 2017, whereas South Korea is expected to register the highest CAGR of 9.7%.

North America held the dominant position in the global market in 2017, and is expected to maintain its lead throughout the analysis period. This is attributed to rise in incidence of spinal fusion & joint reconstruction procedures, sedentary lifestyle contributing to joint disorders in the geriatric & younger population, and favorable reimbursement rates in the region.

The key players profiled in this report include:

  • Arthrex, Inc.
  • Baxter International Inc.
  • Integra LifeSciences Holdings Corporation
  • Johnson & Johnson (DePuy Synthes)
  • Medtronic Plc.
  • Musculoskeletal Transplant Foundation
  • NuVasive, Inc.
  • Stryker Corporation
  • Wright Medical Group N.V.
  • Zimmer Biomet Holdings, Inc.

Source: https://www.globenewswire.com/news-release/2020/06/25/2053539/0/en/Bone-Grafts-Substitutes-Market-to-Reach-3-91-Bn-by-2025.html

Web: https://www.alliedmarketresearch.com

Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research

]]>
North America is estimated to continue to dominate the world market, owing to rise in technological innovations and significant rise in funding. Tue, 01 Dec 2020 19:54:25 +0100 http://comunicati.net/comunicati/istituzioni/comuni/lazio/anguillara_sabazia/675455.html http://comunicati.net/comunicati/istituzioni/comuni/lazio/anguillara_sabazia/675455.html Automotive Market Research Reports Automotive Market Research Reports Global protein labeling market would reach $5,350 million by 2022 from $2,002 million in 2015, growing at a CAGR of 14.9% during the forecast period. Reagents segment is estimated to dominate the global protein labeling market throughout the analysis period. Majority of the global protein labeling market share was captured by U.S. in 2015.

The emerging trends in protein labeling such as emergence of more specific labels with higher affinity and binding properties, bioorthogonal labeling, and customized label designing would fuel the global protein labeling market growth. Such advanced labels help in better marking, identification, separation, and quantification of proteins.

Amongst the labeling methods, the in vivo labeling segment dominates the market with more than half of the global protein labeling market in 2015. This is mainly attributed to ease of availability of products and reagents and the stability of this method. However, bioorthogonal labeling segment is expected to be the fastest growing segment. This is attributed to the fact that this method of proteins labeling can be carried out in living cells without hindering the biochemical functioning of the cell.

Based on geography, North America generated the highest revenue in 2015, accounting for the majority of the share of global protein labeling market, due to various technological advancements, rise in R&D investments, and surge in demand for protein labeling products. Furthermore, North America is estimated to continue to dominate the world market, owing to rise in technological innovations and significant rise in funding. The Asia-Pacific region is expected to be the fastest growing segment, owing to the increased demands of emerging economies such as Japan and China and rise in healthcare expenditure.

Key findings of the Protein Labeling Market Study:

  • Nanoparticle labeling segment is estimated to exhibit a CAGR of 17.4%, among in vitro labeling.
  • Fluorescence Microscopy segment will exhibit a CAGR of 16.1% in LAMEA region.
  • Research laboratories segment holds two-thirds of the share in the end-user protein labeling market.
  • Photoreactive labeling segment for in vivo protein labeling is projected to be the fastest growing segment from 2016 to 2022.
  • Mexico was the smallest economy market in 2015, and is projected to grow at a CAGR of 15.7% through 2022.

The key developmental strategies adopted by leading market players are product launches, collaborations, and partnerships. The prominent market players profiled in the report include General Electric Company, Kaneka Corporation, LI-COR, Inc., Merck & Co., Inc., New England Biolabs, Inc., PerkinElmer, Inc., Promega Corporation, F. Hoffmann-LA Roche AG, Seracare Life Sciences, Inc., and Thermo Fisher Scientific, Inc.

]]>
global UV infection control devices market size was valued at $317.42 million in 2018, and is projected to reach $524.84 million by 2026, registering a CAGR of 6.5% from 2019 to 2026. Fri, 20 Nov 2020 15:15:47 +0100 http://comunicati.net/comunicati/istituzioni/comuni/lazio/comune_di_roma/municipio_roma_xvi/673363.html http://comunicati.net/comunicati/istituzioni/comuni/lazio/comune_di_roma/municipio_roma_xvi/673363.html Automotive Market Research Reports Automotive Market Research Reports The global UV infection control devices market size was valued at $317.42 million in 2018, and is projected to reach $524.84 million by 2026, registering a CAGR of 6.5% from 2019 to 2026.

Key Findings of the Study:

  • By type, the mobile device segment occupied around half share of the global UV infection control devices market in 2018.
  • By end user, the hospitals segment is anticipated to grow with the highest CAGR throughout the forecast period.
  • By type, the others segment accounted for more than two-fifths share of the market in 2018.
  • BY region, Asia-Pacific is anticipated to grow at the highest rate during the analysis period, followed by LAMEA.

The end user segment to dominate during the estimated period-

Based on end user, the hospital segment held the major share in 2018, generating nearly half of the global UV infection control market. The segment is anticipated to maintain its dominance throughout the forecast period.

Moreover, the same segment would showcase the fastest CAGR of 6.8% during the study period. This is attributed to the fact that hospitals receive different types of patients that require surgeries, which leads to increase the adoption of UV infection control devices and therefore drives the growth of the segment.

Frontrunners in the industry-

  • CVS Health Corporation
  • DocMorris
  • Express Scripts Holding Company
  • Giant Eagle Inc.
  • Optum Rx Inc.
  • Rowlands Pharmacy
  • The Kroger Co.
  • Walgreen Co.
  • Walmart Stores Inc.
  • Apollo Pharmacy

Source:

https://www.whatech.com/markets-research/medical/673751-uv-infection-control-devices-market-to-garner-317-42-million-by-2023-at-6-5-cagr

]]>
Trimethallyl isocyanurate (TMAIC) Market Overview, Growing Demand and Scope 2019 to 2026 Thu, 19 Nov 2020 11:42:49 +0100 http://comunicati.net/comunicati/istituzioni/comuni/lazio/comune_di_roma/municipio_roma_xv/673095.html http://comunicati.net/comunicati/istituzioni/comuni/lazio/comune_di_roma/municipio_roma_xv/673095.html Ethan Smith Ethan Smith

 

 
]]>
Trimethallyl isocyanurate (TMAIC) Market Overview, Growing Demand and Scope 2019 to 2026 Thu, 19 Nov 2020 11:41:06 +0100 http://comunicati.net/comunicati/istituzioni/comuni/lazio/comune_di_roma/municipio_roma_xv/673094.html http://comunicati.net/comunicati/istituzioni/comuni/lazio/comune_di_roma/municipio_roma_xv/673094.html Ethan Smith Ethan Smith

 

 
]]>